Research ArticleArticle
Open Access
Livedo Reticularis After COVID-19 Vaccination
Taro Horino, Satoshi Inotani, Kimiko Nakajima and Yoshio Terada
The Journal of Rheumatology October 2022, jrheum.220584; DOI: https://doi.org/10.3899/jrheum.220584
Taro Horino
Taro Horino, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Satoshi Inotani, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Kimiko Nakajima, MD, PhD, Department of Dermatology, Kochi Medical School, Kochi University; Yoshio Terada, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan. Address correspondence to Dr. T. Horino, Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan. Email: horinott@yahoo.co.jp. The authors declare no conflicts of interest relevant to this article. Ethics board approval was not required because this is a single case report, and no intervention was provided to the patient during this research. Written informed consent was obtained from the patient to publish the material.
Satoshi Inotani
Taro Horino, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Satoshi Inotani, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Kimiko Nakajima, MD, PhD, Department of Dermatology, Kochi Medical School, Kochi University; Yoshio Terada, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan. Address correspondence to Dr. T. Horino, Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan. Email: horinott@yahoo.co.jp. The authors declare no conflicts of interest relevant to this article. Ethics board approval was not required because this is a single case report, and no intervention was provided to the patient during this research. Written informed consent was obtained from the patient to publish the material.
Kimiko Nakajima
Taro Horino, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Satoshi Inotani, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Kimiko Nakajima, MD, PhD, Department of Dermatology, Kochi Medical School, Kochi University; Yoshio Terada, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan. Address correspondence to Dr. T. Horino, Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan. Email: horinott@yahoo.co.jp. The authors declare no conflicts of interest relevant to this article. Ethics board approval was not required because this is a single case report, and no intervention was provided to the patient during this research. Written informed consent was obtained from the patient to publish the material.
Yoshio Terada
Taro Horino, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Satoshi Inotani, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University; Kimiko Nakajima, MD, PhD, Department of Dermatology, Kochi Medical School, Kochi University; Yoshio Terada, MD, PhD, Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan. Address correspondence to Dr. T. Horino, Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi 783-8505, Japan. Email: horinott@yahoo.co.jp. The authors declare no conflicts of interest relevant to this article. Ethics board approval was not required because this is a single case report, and no intervention was provided to the patient during this research. Written informed consent was obtained from the patient to publish the material.
Abstract
Livedo reticularis occurs when there is increased visibility of the venous plexus, often caused by reduced arterial inflow or venodilation.1 Although livedo reticularis has been reported in patients with COVID-19,2,3 it has also been reported following COVID-19 vaccination.4
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Livedo Reticularis After COVID-19 Vaccination
Taro Horino, Satoshi Inotani, Kimiko Nakajima, Yoshio Terada
The Journal of Rheumatology Oct 2022, jrheum.220584; DOI: 10.3899/jrheum.220584